Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection

Published:2016-10 Issue:40 Volume:95 Page:e4989
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Cai Xiao-Yan,Ni Xiao-Chun,Yi Yong,He Hong-Wei,Wang Jia-Xing,Fu Yi-Peng,Sun Jian,Zhou Jian,Cheng Yun-Feng,Jin Jian-Jun,Fan Jia,Qiu Shuang-Jian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference40 articles.

1. New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape;Mittal;Curr Opin Immunol,2014

2. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment;Croci;Cancer Immunol Immunother,2007

3. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma;Shi;Hepatology,2010

4. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma;Gao;Clin Cancer Res,2009

5. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma;Gao;Cancer Res,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity;International Immunopharmacology;2024-10

2. Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation;Molecular Therapy: Oncology;2024-09

3. Landmark analysis of the risk of recurrence after resection or ablation for HCC: A nationwide study;Hepatology Communications;2024-06-19

4. Regulatory role of CD39 and CD73 in tumor immunity;Future Oncology;2024-04-23

5. Nanoparticles targeting the adenosine pathway for cancer immunotherapy;Journal of Materials Chemistry B;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3